Preclinical Efficacy of a PSMA-targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-2268
Full Text
Open PDFAbstract
Available in full text
Date
December 12, 2019
Authors
Publisher
American Association for Cancer Research (AACR)